| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-11 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-08 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-05 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |